A medication previously studied in patients with Alzheimer’s disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory skills among individuals with Huntington’s disease, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.
Parkinson disease is a chronic and progressive nerve disorder that that cause uncontrollable shaking and trembling, a fixed staring expression, muscle.
A medication previously studied in patients with Alzheimer’s disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory skills among individuals with Huntington’s disease , according to a report in the …
( University of Rochester Medical Center ) An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington’s disease appears to be safe and may improve cognition. That is the conclusion of a study published today in the Archives of Neurology.
( JAMA and Archives Journals ) A medication previously studied in patients with Alzheimer’s disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory skills among individuals with Huntington’s disease, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.